UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

The Lancet (British edition), 2020-05, Vol.395 (10237), p.1613-1626

2020

Link zum Volltext

Verfügbarkeit prüfen

Hypofractionation: The standard for external beam breast irradiation

Breast (Edinburgh), 2023-06, Vol.69, p.410-416

2023

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer radiation therapy – Authors' reply

The Lancet (British edition), 2020-11, Vol.396 (10262), p.1559-1560

2020

Link zum Volltext

Verfügbarkeit prüfen

One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT

Health technology assessment (Winchester, England), 2023-11, Vol.27 (25), p.1-176

2023

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Management Guidelines During COVID-19 Pandemic

Indian journal of surgery, 2020-06, Vol.82 (3), p.251-258

2020

Link zum Volltext

Verfügbarkeit prüfen

The challenge of equipoise: qualitative interviews exploring the views of health professionals and women with multiple ipsilateral breast cancer on recruitment to a surgical randomised controlled feasibility trial

Pilot and feasibility studies, 2022-02, Vol.8 (1), p.46-46, Article 46

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial

Clinical cancer research, 2019-07, Vol.25 (14), p.4248-4254

2019

Link zum Volltext

Verfügbarkeit prüfen

Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer

Journal of clinical oncology, 2020-10, Vol.38 (28), p.3261-3272

2020

Link zum Volltext

Verfügbarkeit prüfen

Aromatase inhibition plus/minus Src inhibitor saracatinib : a randomised phase II study

Breast cancer research and treatment, 2023-05, Vol.199 (1), p.35

2023

Link zum Volltext

Verfügbarkeit prüfen

Aromatase inhibition plus/minus Src inhibitor saracatinib

Breast cancer research and treatment, 2023-05, Vol.199 (1), p.35

2023

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis

Breast cancer research and treatment, 2023, Vol.197 (2), p.405-416

2023

Link zum Volltext

Verfügbarkeit prüfen

Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study

Breast cancer research and treatment, 2023-05, Vol.199 (1), p.35-46

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-13-08: Combined peri-operative lapatinib and trastuzumab in early HER2-positive breast cancer - Long term results of the randomized UK EPHOS-B trial

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-13-08

2022

Link zum Volltext

Verfügbarkeit prüfen

Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

Clinical cancer research, 2022-04, Vol.28 (7), p.1323-1334

2022

Link zum Volltext

Verfügbarkeit prüfen

Epileptic seizure abolition with aromatase inhibition

Journal of neurology, neurosurgery and psychiatry, 2012-12, Vol.83 (12), p.1249-1250

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparison of CT-volumed supraclavicular fossa radiotherapy planning and conventional simulator-planned defined by bony landmarks for early breast cancer

Reports of practical oncology and radiotherapy, 2016-05, Vol.21 (3), p.219-224

2016

Link zum Volltext

Verfügbarkeit prüfen

Dose Fractionation

Breast Cancer Radiation Therapy, p.103-109

Link zum Volltext

Verfügbarkeit prüfen

Epileptic seizure abolition with aromatase inhibition

Journal of neurology, neurosurgery, and psychiatry, 2012, Vol.83 (12), p.1249-1250

2012

Link zum Volltext

Verfügbarkeit prüfen

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

Radiotherapy and oncology, 2016-07, Vol.120 (1), p.114-118

2016

Link zum Volltext

Verfügbarkeit prüfen

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015)

Radiotherapy and oncology, 2011-07, Vol.100 (1), p.93-100

2011

Link zum Volltext

Verfügbarkeit prüfen

Breast-Cancer Adjuvant Therapy with Zoledronic Acid

The New England journal of medicine, 2011-10, Vol.365 (15), p.1396-1405

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Englisch
(29)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Breast Cancer
(16)
Female
(16)
Humans
(16)
Oncology
(14)
Breast Neoplasms - Radiotherapy
(10)
Breast Neoplasms - Pathology
(7)
Middle Aged
(6)
Radiology, Nuclear Medicine & Medical Imaging
(6)
Radiotherapy
(6)
Aged
(5)
Aged, 80 And Over
(5)
Cancer Therapies
(5)
Clinical Trials
(5)
Hypofractionation
(5)
Menopause
(5)
Radiotherapy Dosage
(5)
United Kingdom
(5)
Adult
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial

Hypofractionation: The standard for external beam breast irradiation

Breast cancer radiation therapy – Authors' reply

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial

One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT

Breast Cancer Management Guidelines During COVID-19 Pandemic

The challenge of equipoise: qualitative interviews exploring the views of health professionals and women with multiple ipsilateral breast cancer on recruitment to a surgical randomised controlled feasibility trial

Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial

Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer

Aromatase inhibition plus/minus Src inhibitor saracatinib : a randomised phase II study

Aromatase inhibition plus/minus Src inhibitor saracatinib

Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis

Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study

Abstract P2-13-08: Combined peri-operative lapatinib and trastuzumab in early HER2-positive breast cancer - Long term results of the randomized UK EPHOS-B trial

Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

Abstract PD1-11: Mature survival update of the double-blind placebo-controlled randomised phase II PAKT trial of first-line capivasertib plus paclitaxel for metastatic triple-negative breast cancer

Epileptic seizure abolition with aromatase inhibition

Comparison of CT-volumed supraclavicular fossa radiotherapy planning and conventional simulator-planned defined by bony landmarks for early breast cancer

Dose Fractionation

Epileptic seizure abolition with aromatase inhibition

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015)

Breast-Cancer Adjuvant Therapy with Zoledronic Acid

Suchergebnisse filtern